Skip to main content

Table 2 Demographic and clinical characteristics of Group II patients treated with kyphoplasty

From: Reduction of the domino effect in osteoporotic vertebral compression fractures through short-segment fixation with intravertebral expandable pillars compared to percutaneous kyphoplasty: a case control study

Group II

Gender

Age (y/o)

Level

VAS

AH (mm)

KA (°)

AH above (mm)

AH below (mm)

KA above (°)

KA below (°)

VAS

AH (mm)

KA (°)

AH above (mm)

AH below (mm)

KA above (°)

KA below (°)

    

Pre OP

Post OP 1Y

1

F

84

T12

8

16.08

20.3

24.9

26.4

2.02

1.01

3

16.76

0.89

9.8

27.2

12.3

3.2

2

M

79

L1

7.5

11

19.4

25

26.7

4.2

6.2

2.5

20.74

0.91

25.2

26.2

4.4

6.6

3

M

80

T12

8

6.32

21.23

24.8

27.5

10.8

12.21

2

19.96

8.5

20.4

27.1

11

9

4

F

84

L1

8

11.16

25

27

29.2

2.5

2.1

3

23.54

1.26

27.1

29.1

2.4

2.2

5

M

74

T10

6

8.61

18.6

14.4

25.7

6.8

4.3

1

15.62

1.8

15

25.6

7.6

4.4

6

F

85

T12

8

17.2

20.02

23.6

28.6

7.2

1.8

2

20.2

9.53

19.3

24.4

7.6

6.9

7

F

84

T12

8

11.4

24.41

23.5

25.3

5.8

6.2

2.5

16.63

9.19

23.2

25.3

5.5

6.3

8

F

85

L3

7.5

8.16

19

16.9

28.1

16.1

0

2.5

35.62

0.68

14.3

25.5

14.1

2

9

F

73

L1

8

16.85

16.9

25.8

29.8

4.6

0.2

1.5

14.4

0.27

25.7

29.8

4.5

0.3

10

M

76

L3

8.5

31.02

21

18

33.7

15.9

4.3

2

32.47

2.14

16.8

33.3

18

4.4

11

F

71

L3

8

33.33

18.3

28.1

21.9

0.45

11.73

1.5

33.64

0.89

23.3

22

3.2

9.8

12

M

88

L1

7

12.19

19.58

25.8

32.7

8.1

1.9

2.5

15.08

1.42

25.7

32.7

8.2

1.8

13

M

79

T12

8.5

10.85

23.82

25.2

29.1

7.7

4.7

1.5

20.82

2.01

25.3

29

7.5

4.9

14

F

56

L1

7.5

6.4

30

7.4

25

31.8

7.6

2.5

11.22

0.2

6.2

22.2

33.1

6.3

15

M

76

L2

8

7

24

28.9

24.1

8.3

12.7

3.5

20.3

1.66

28.2

24.3

8.4

12.6

16

F

90

L1

7.5

20.3

11.48

14

25.6

10.4

7.2

3

20.5

1.88

10.9

19.8

8.6

8.8

17

F

78

L3

8.5

21

20.04

17

28

19

4.8

2

26.6

5.39

14

28

16

3

18

F

82

L1

8.5

24.8

15.44

27.2

33.3

7.1

1.2

3

20.15

5.66

27.4

33.3

7.3

1.3

19

F

79

T12

8

14.17

26.12

21.5

30

11

5.6

2

18.72

2.2

20.3

29.6

11.2

5.5

20

F

85

L1

9

9.6

28.64

16.7

34.3

3.02

1

1

17

1.88

15.8

28.9

5.8

1.2

21

F

71

L3

8

21.8

26.59

27.5

30.6

7.2

1.1

1.5

24.95

2.93

27.5

30.5

7.3

1.1

22

F

82

L3

8

13.75

23.9

15

30

14.3

1.6

1

17.75

1.91

14.8

29.6

13.2

1.7

23

F

78

L2

9

20.65

17.25

27.6

36.2

4.3

4.9

2

30.63

2.26

27.4

35.9

4.4

4.8

24

F

84

T10

8

19.25

26.5

14.7

17.8

15

7.9

1

20.2

0.49

14.5

17

15.2

8

Minima

 

71

 

6

6.32

11.48

7.4

17.8

0.45

0

1

11.22

0.2

6.2

17

2.4

0.3

Maxima

 

90

 

9

33.33

30

28.9

36.3

31.8

12.7

3.5

35.62

9.53

28.8

36.9

33.1

12.6

Mean

 

79.3

 

7.95

15.54

21.58

21.69

28.33

9.32

4.68

2.08

21.36

2.75

19.95

27.35

9.87

4.84

SD

 

7

 

0.61

7.22

4.35

5.77

4.08

6.71

3.7

0.72

6.24

2.72

6.43

4.37

6.36

3.17

  1. VAS = visual analogue scale; AH = anterior height of the fractured vertebra; KA = kyphotic angle of the fractured vertebra; AH above = anterior height above the fractured vertebra; AH below = anterior height below the fractured vertebra; SD = standard deviation.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us